JP2000502320A5 - - Google Patents

Download PDF

Info

Publication number
JP2000502320A5
JP2000502320A5 JP1997506287A JP50628797A JP2000502320A5 JP 2000502320 A5 JP2000502320 A5 JP 2000502320A5 JP 1997506287 A JP1997506287 A JP 1997506287A JP 50628797 A JP50628797 A JP 50628797A JP 2000502320 A5 JP2000502320 A5 JP 2000502320A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1997506287A
Other languages
English (en)
Japanese (ja)
Other versions
JP2000502320A (ja
JP3920919B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP1996/003129 external-priority patent/WO1997004005A2/de
Publication of JP2000502320A publication Critical patent/JP2000502320A/ja
Publication of JP2000502320A5 publication Critical patent/JP2000502320A5/ja
Application granted granted Critical
Publication of JP3920919B2 publication Critical patent/JP3920919B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP50628797A 1995-07-17 1996-07-17 抗−hiv−作用を有するシクロスポリン誘導体 Expired - Fee Related JP3920919B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP95111162 1995-07-17
EP95111162.4 1995-07-17
PCT/EP1996/003129 WO1997004005A2 (de) 1995-07-17 1996-07-17 Cyclosporin-derivate mit anti-hiv-wirkung

Publications (3)

Publication Number Publication Date
JP2000502320A JP2000502320A (ja) 2000-02-29
JP2000502320A5 true JP2000502320A5 (cg-RX-API-DMAC10.html) 2004-08-19
JP3920919B2 JP3920919B2 (ja) 2007-05-30

Family

ID=8219438

Family Applications (1)

Application Number Title Priority Date Filing Date
JP50628797A Expired - Fee Related JP3920919B2 (ja) 1995-07-17 1996-07-17 抗−hiv−作用を有するシクロスポリン誘導体

Country Status (17)

Country Link
US (1) US5948884A (cg-RX-API-DMAC10.html)
EP (1) EP0842191B1 (cg-RX-API-DMAC10.html)
JP (1) JP3920919B2 (cg-RX-API-DMAC10.html)
KR (1) KR100441220B1 (cg-RX-API-DMAC10.html)
CN (1) CN1141317C (cg-RX-API-DMAC10.html)
AT (1) ATE209216T1 (cg-RX-API-DMAC10.html)
AU (1) AU722858B2 (cg-RX-API-DMAC10.html)
BR (1) BR9609795A (cg-RX-API-DMAC10.html)
CA (1) CA2226880C (cg-RX-API-DMAC10.html)
CZ (1) CZ290754B6 (cg-RX-API-DMAC10.html)
DE (1) DE59608274D1 (cg-RX-API-DMAC10.html)
HU (1) HUP9900405A3 (cg-RX-API-DMAC10.html)
IL (1) IL122754A (cg-RX-API-DMAC10.html)
NO (1) NO980195L (cg-RX-API-DMAC10.html)
NZ (1) NZ315324A (cg-RX-API-DMAC10.html)
PL (1) PL324531A1 (cg-RX-API-DMAC10.html)
WO (1) WO1997004005A2 (cg-RX-API-DMAC10.html)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2757521B1 (fr) * 1996-12-24 1999-01-29 Rhone Poulenc Rorer Sa Nouveaux derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2757520B1 (fr) * 1996-12-24 1999-01-29 Rhone Poulenc Rorer Sa Derive de cyclosporine, sa preparation et les compositions pharmaceutiques qui le contiennent
FR2757522B1 (fr) * 1996-12-24 1999-01-29 Rhone Poulenc Rorer Sa Derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2762843B1 (fr) * 1997-04-30 1999-12-10 Rhone Poulenc Rorer Sa Nouveaux derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent
US6316405B1 (en) * 1997-08-26 2001-11-13 Wisconsin Alumni Research Foundation Cyclosporin a conjugates and uses therefor
US6270957B1 (en) 1997-08-26 2001-08-07 Wisconsin Alumni Research Foundation Non-Imuunosuppressive cyclosporins and their use in the prevention and treatment of HIV infection
US20030220234A1 (en) 1998-11-02 2003-11-27 Selvaraj Naicker Deuterated cyclosporine analogs and their use as immunodulating agents
FR2772768B1 (fr) * 1997-12-19 2000-01-14 Rhone Poulenc Rorer Sa Nouveau procede de preparation de derives de cyclosporine
DK1086124T3 (da) 1998-06-12 2004-03-29 Chem Ag C Nye cyclosporiner
BR9911724A (pt) 1998-07-01 2001-03-20 Debiopharm Sa Ciclosporina que tem um perfil de atividade melhorado
KR100465012B1 (ko) * 2001-05-11 2005-01-13 주식회사 엘지생활건강 모발 성장 효과를 갖는 사이클로스포린 3 위치 유도체를유효성분으로 하는 모발 성장 촉진제
SI1436321T1 (sl) 2001-10-19 2006-12-31 Isotechnika Inc Sinteza analogov ciklosporina
US7108988B2 (en) 2001-11-02 2006-09-19 The J. David Gladstone Institutes Methods of identifying agents for inhibiting lentivirus replication
US6987090B2 (en) * 2002-05-09 2006-01-17 Lg Household & Health Care Ltd. Use of 3-position cyclosporin derivatives for hair growth
JP2006524232A (ja) * 2003-03-17 2006-10-26 アルバニー モレキュラー リサーチ インコーポレーティッド 新規サイクロスポリン
US7378391B2 (en) 2004-09-29 2008-05-27 Amr Technology, Inc. Cyclosporin alkyne analogues and their pharmaceutical uses
EP1804823A4 (en) * 2004-09-29 2010-06-09 Amr Technology Inc NEW CYCLOSPORIN ANALOGUE AND ITS PHARMACEUTICAL APPLICATIONS
US7196161B2 (en) * 2004-10-01 2007-03-27 Scynexis Inc. 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis C infection
KR101309409B1 (ko) * 2004-10-01 2013-09-23 싸이넥시스, 인크. C형 간염 바이러스 감염의 치료 및 예방을 위한 3-에테르및 3-티오에테르 치환된 시클로스포린 유도체
US7361636B2 (en) 2004-10-06 2008-04-22 Amr Technology, Inc. Cyclosporin alkynes and their utility as pharmaceutical agents
WO2007041631A1 (en) * 2005-09-30 2007-04-12 Scynexis, Inc. ARYIiALKYL AND HETEROARYLALKYL DERIVATIVES OF CYCLOSPORINE A FOR THE TREATMENT AND PREVENTION OF VIRAL INFECTION
BRPI0616476A2 (pt) * 2005-09-30 2011-06-21 Scynexis Inc uso de uma quantidade terapeuticamente eficaz de um derivado de ciclosporina, e, composição farmacêutica
US7696166B2 (en) * 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders
US7696165B2 (en) * 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
US20070232532A1 (en) * 2006-03-28 2007-10-04 Amr Technology, Inc. Use of cyclosporin alkene analogues for preventing or treating viral-induced disorders
ES2361635T3 (es) 2006-05-19 2011-06-20 Scynexis, Inc. Ciclosporinas para el tratamiento y prevención de trastornos oculares.
EP2027761A1 (fr) * 2006-06-02 2009-02-25 Claude Annie Perrichon Gestion des electrons actifs
WO2008069917A2 (en) 2006-11-20 2008-06-12 Scynexis, Inc. Novel cyclic peptides
US20080255038A1 (en) * 2007-04-11 2008-10-16 Samuel Earl Hopkins Pharmaceutical compositions
JP5820722B2 (ja) * 2008-06-06 2015-11-24 スシネキス インク シクロスポリン類似体及びhcv感染の治療におけるその使用
WO2009148615A1 (en) * 2008-06-06 2009-12-10 Scynexis, Inc. Cyclosporin analogs and their use in the treatment of hcv infections
DE102008060549A1 (de) 2008-12-04 2010-06-10 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Wirkstoff-Peptid-Konstrukt zur extrazellulären Anreicherung
CA2748389A1 (en) 2008-12-31 2010-07-08 Scynexis, Inc. Derivatives of cyclosporin a
CN101874902B (zh) * 2009-06-19 2013-04-03 清华大学 一种用于人工椎间盘髓核假体材料的制备方法
US20120010131A1 (en) * 2009-12-30 2012-01-12 Scynexis, Inc. Novel cyclosporin analogues
US9573978B2 (en) 2010-08-12 2017-02-21 S&T Global, Inc. Cyclosporin derivatives for the treatment and prevention of a viral infection
JP6093307B2 (ja) * 2010-12-03 2017-03-08 エス アンド ティー グローバル インク. ウイルス感染の治療および予防のための新規シクロスポリン誘導体
US9890198B2 (en) 2010-12-03 2018-02-13 S&T Global Inc. Cyclosporin derivatives and uses thereof
MY192981A (en) 2010-12-15 2022-09-20 Contravir Pharmaceuticals Inc Cyclosporine analogue molecules modified at amino acid 1 and 3
EP2705856A1 (en) 2012-09-07 2014-03-12 Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. Compounds for the treatment of neurodegenerative disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0194972B1 (en) * 1985-03-11 1992-07-29 Sandoz Ag Novel cyclosporins
US5122511A (en) * 1990-02-27 1992-06-16 Merck & Co., Inc. Immunosuppressive cyclosporin analogs with modified amino acids at position-8
DE69124459T3 (de) * 1990-11-02 2001-05-31 Novartis Ag, Basel Zyklosporine

Similar Documents

Publication Publication Date Title
JP2000500445A5 (cg-RX-API-DMAC10.html)
JP2000501064A5 (cg-RX-API-DMAC10.html)
JP2000500228A5 (cg-RX-API-DMAC10.html)
JP2000500440A5 (cg-RX-API-DMAC10.html)
JP2000512994A5 (cg-RX-API-DMAC10.html)
JP2000500327A5 (cg-RX-API-DMAC10.html)
JP2000500145A5 (cg-RX-API-DMAC10.html)
JP2000500155A5 (cg-RX-API-DMAC10.html)
JP2000500406A5 (cg-RX-API-DMAC10.html)
JP2000500115A5 (cg-RX-API-DMAC10.html)
JP2000500322A5 (cg-RX-API-DMAC10.html)
JP2000500258A5 (cg-RX-API-DMAC10.html)
JP2000500192A5 (cg-RX-API-DMAC10.html)
JP2000500112A5 (cg-RX-API-DMAC10.html)
JP2000502320A5 (cg-RX-API-DMAC10.html)
JP2000500226A5 (cg-RX-API-DMAC10.html)
JP2000500051A5 (cg-RX-API-DMAC10.html)
JP2000500407A5 (cg-RX-API-DMAC10.html)
JP2000500019A5 (cg-RX-API-DMAC10.html)
JP2000500166A5 (cg-RX-API-DMAC10.html)
JPH11512193A5 (cg-RX-API-DMAC10.html)
JP2000500125A5 (cg-RX-API-DMAC10.html)
JP2000511778A5 (cg-RX-API-DMAC10.html)
JP2000500044A5 (cg-RX-API-DMAC10.html)
JP2000500257A5 (cg-RX-API-DMAC10.html)